Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82,014 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis.
Jin P, Jiang J, Zhou L, Huang Z, Qin S, Chen HN, Peng L, Zhang Z, Li B, Luo M, Zhang T, Ming H, Ding N, Li L, Xie N, Gao W, Zhang W, Nice EC, Wei Y, Huang C. Jin P, et al. Among authors: zhang w, zhang t, zhang z. EMBO Mol Med. 2022 Dec 7;14(12):e16082. doi: 10.15252/emmm.202216082. Epub 2022 Nov 2. EMBO Mol Med. 2022. PMID: 36321555 Free PMC article.
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.
Gan L, Lang M, Tian X, Ren S, Li G, Liu Y, Han R, Zhu K, Li H, Wu Q, Cui Y, Zhang W, Fang F, Li Q, Song T. Gan L, et al. Among authors: zhang w. J Hepatocell Carcinoma. 2023 Apr 22;10:673-686. doi: 10.2147/JHC.S404675. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37125392 Free PMC article.
82,014 results
You have reached the last available page of results. Please see the User Guide for more information.